Common Herbal Dietary Supplement-Drug Interactions.
暂无分享,去创建一个
[1] J. Werba,et al. The effect of green tea on simvastatin tolerability. , 2008, Annals of internal medicine.
[2] K. Rentsch,et al. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] Bruce E. Bray,et al. Ginkgo and Warfarin Interaction in a Large Veterans Administration Population , 2015, AMIA.
[4] C. Flexner,et al. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir , 2008, BMC complementary and alternative medicine.
[5] D. K. Williams,et al. Effect of Goldenseal (Hydrastis canadensis) and Kava Kava (Piper methysticum) Supplementation on Digoxin Pharmacokinetics in Humans , 2007, Drug Metabolism and Disposition.
[6] Bill Gurley,et al. Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin , 2006, Journal of clinical pharmacology.
[7] G. Anderson,et al. Drug Interaction Potential of Soy Extract and Panax Ginseng , 2003, Journal of clinical pharmacology.
[8] D. K. Williams,et al. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS , 2006, Drug Metabolism and Disposition.
[9] J. Kovacs,et al. Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P‐glycoprotein (P‐gp) Activity in Healthy Participants , 2012, Journal of clinical pharmacology.
[10] A. Mitchell,et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.
[11] P. Neuvonen,et al. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. , 2007, Clinical pharmacology and therapeutics.
[12] S. Misaka,et al. Inhibitory Effects of Green Tea and (–)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein , 2015, PloS one.
[13] A. Shaughnessy,et al. Herbal and dietary supplement--drug interactions in patients with chronic illnesses. , 2008, American family physician.
[14] J. Falloon,et al. The effect of garlic supplements on the pharmacokinetics of saquinavir. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] D. K. Williams,et al. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. , 2008, Molecular nutrition & food research.
[16] R. Hoerr,et al. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers , 2011, European Journal of Clinical Pharmacology.
[17] R. Ballard-Barbash,et al. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. , 2008, Journal of the American Dietetic Association.
[18] D. Greenblatt,et al. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers , 2013, British journal of clinical pharmacology.
[19] K. Maeda,et al. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP , 2012, British journal of pharmacology.
[20] R. Day,et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2004, British journal of clinical pharmacology.
[21] I. Khan,et al. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes , 2005, Clinical pharmacology and therapeutics.
[22] Y. Sawada,et al. EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2006, Drug Metabolism And Disposition.
[23] P. Barnes,et al. Complementary and alternative medicine use among adults and children: United States, 2007. , 2008, National health statistics reports.
[24] J. Donovan,et al. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS , 2004, Drug Metabolism and Disposition.
[25] P. Barnes,et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. , 2015, National health statistics reports.
[26] S. Gardner,et al. Clinical Assessment of Effects of Botanical Supplementation on Cytochrome P450 Phenotypes in the Elderly , 2005, Drugs & aging.
[27] Shiew-Mei Huang,et al. The Effect of Echinacea (Echinacea purpurea Root) on Cytochrome P450 Activity in Vivo , 2004, Clinical pharmacology and therapeutics.
[28] Nima M. Patel,et al. Possible Increase in Liver Enzymes Secondary to Atorvastatin and Black Cohosh Administration , 2007 .
[29] M. Schwab,et al. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.
[30] Honghao Zhou,et al. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers , 2009, European Journal of Clinical Pharmacology.
[31] J. Donovan,et al. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers , 2003, Clinical pharmacology and therapeutics.
[32] D. K. Williams,et al. Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo , 2008, Clinical pharmacology and therapeutics.
[33] I. Khan,et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto , 2004, Clinical pharmacology and therapeutics.
[34] Honghao Zhou,et al. Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in Healthy, Male Chinese Volunteers , 2010, The Annals of pharmacotherapy.
[35] A. Burstein,et al. St John's Wort: Effect on CYP3A4 activity , 2000 .
[36] J. Markowitz,et al. The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity , 2014, Drug Metabolism and Disposition.
[37] L. Dey,et al. American ginseng reduces warfarin’s effect in healthy patients: A randomized, controlled trial☆ , 2004 .
[38] A. Etheridge,et al. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[39] Honghao Zhou,et al. St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole , 2004, Clinical pharmacology and therapeutics.
[40] S. Misaka,et al. Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects , 2014, Clinical pharmacology and therapeutics.
[41] D. Carrier,et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. , 2008, Molecular nutrition & food research.
[42] J. Donovan,et al. MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS , 2004, Drug Metabolism and Disposition.
[43] C. Flexner,et al. Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius , 2008, Journal of clinical pharmacology.
[44] B. Crabtree,et al. ’They Don’t Ask Me So I Don’t Tell Them’: Patient-Clinician Communication About Traditional, Complementary, and Alternative Medicine , 2009, The Annals of Family Medicine.
[45] M. Ford,et al. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. , 2010, British journal of clinical pharmacology.
[46] R. Day,et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2005, British journal of clinical pharmacology.